Testing SHR-4610 for advanced solid tumors
Treatments studied
Part of Cancer clinical trials.
This trial tests a new drug called SHR-4610 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe and effective, and may be an option if you have a measurable tumor and are generally in good health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old
- You have advanced cancer that has spread or cannot be removed, and standard treatments have stopped working or are not available
- You have at least one tumor that can be measured on a scan
- You are generally able to take care of yourself (ECOG score 0 or 1)
- You do not have active cancer spread to the brain or uncontrolled heart problems, and your hepatitis B/C is not active
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new experimental drug, SHR-4375, for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and effective for these cancers.
This trial tests an investigational drug called SHR-8203 for people with advanced solid tumors that have stopped responding to standard treatments or for whom no standard treatment exists. The goal is to see if the drug can shrink tumors or slow their growth.
This study tests two new experimental drugs (HRS-4642 and SHR-A2102) given together to people with advanced solid tumors. The goal is to see if the combination is safe and helps shrink tumors or slow their growth.
This trial tests a new drug, SHR-4506, for people with advanced cancers that have stopped responding to standard treatments or cannot be treated with standard options. It aims to see if the drug is safe and helpful.
This study tests a new drug called SHR-4375 combined with other cancer treatments for people with advanced solid tumors that haven't gotten better with standard care. The goal is to see if the combination is safe and works against the cancer.
This trial is testing an investigational drug called SHR-7787 for people with advanced solid tumors (cancer that has spread or can't be removed). The goal is to see if it is safe and how well it works. It may be an option if your tumor type is no longer responding to other treatments.
Hear when a new Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.